Lantus SoloStar is a prefilled, disposable insulin pen that delivers insulin glargine, a long-acting insulin used to manage blood sugar in people with Type 1 or Type 2 diabetes. The pen allows you to dial doses from 1 to 80 units in single-unit increments, and each injection provides steady insulin coverage for up to 24 hours.
How Lantus Works in Your Body
Insulin glargine, the active drug inside the SoloStar pen, is a lab-made version of human insulin designed to dissolve slowly after injection. The solution inside the pen is slightly acidic, which keeps the insulin fully dissolved. Once it enters the tissue beneath your skin, your body’s neutral pH causes the insulin to form tiny solid clusters called microprecipitates. These clusters break down gradually, releasing small, consistent amounts of insulin over roughly 24 hours.
This slow-release design is what makes Lantus different from rapid-acting or short-acting insulins. There’s no sharp spike in activity. Instead, it maintains a relatively flat level of insulin throughout the day, mimicking the low, steady baseline of insulin that a healthy pancreas produces between meals and overnight. That’s why it’s taken once daily and is often called a “basal” insulin.
Who Uses Lantus SoloStar
People with Type 1 diabetes use Lantus as their background insulin, typically alongside a fast-acting insulin taken at mealtimes. For Type 2 diabetes, Lantus may be prescribed alone or combined with oral blood sugar medications when those pills aren’t enough on their own. It’s approved for adults and for children with Type 1 diabetes.
How to Use the SoloStar Pen
The SoloStar pen is designed for simplicity. You attach a new pen needle, perform a safety test, dial your dose, inject, and dispose of the needle. A few steps deserve extra attention.
The Safety Test
Before every injection, you need to prime the pen to clear air bubbles and confirm insulin is flowing. Dial 2 units, point the needle upward, and press the injection button all the way in. You should see a drop of insulin at the needle tip. If nothing appears, repeat the test. If insulin still doesn’t come out after three attempts, swap to a new needle and try again.
Choosing and Rotating Injection Sites
Common injection areas include the abdomen, upper thighs, and backs of the upper arms. The key habit to build is rotating your injection site within the same general area. Injecting in the same exact spot repeatedly can cause the skin and fat tissue to change. Some people develop lipohypertrophy, where the tissue thickens or enlarges into a firm lump, while others experience lipoatrophy, where the skin develops a visible depression. Both problems can alter how consistently your body absorbs insulin, making blood sugar harder to predict. Moving your injection point by an inch or two each time helps prevent this.
Dose Range and Flexibility
The SoloStar pen dials in 1-unit steps, giving you precise control over your dose. The minimum is 1 unit and the maximum is 80 units per injection. If your prescribed dose is higher than 80 units, you’d need two injections. The dose window on the pen shows your selected number clearly, which is especially helpful for people who inject at night or in low light.
Storing Your Pen
Unopened SoloStar pens belong in the refrigerator, between 36°F and 46°F. Don’t freeze them. Once you start using a pen, it can stay at room temperature (59°F to 86°F) for up to 28 days. After 28 days, throw it away even if insulin remains inside, because the drug’s stability can no longer be guaranteed. Keep the pen cap on when you’re not using it, and never store it with a needle attached, as temperature changes can cause insulin to leak or air to enter the cartridge.
Common Side Effects
Low blood sugar (hypoglycemia) is the most frequent side effect of any insulin, Lantus included. In clinical trials, the risk varied depending on the type of diabetes and what other insulin or medications were used alongside it. For adults with Type 2 diabetes using Lantus with oral medications, about 1.7% experienced severe low blood sugar over a year. For adults with Type 1 diabetes, where Lantus is paired with mealtime insulin, that rate ranged from roughly 6.5% to 10.6% depending on the study.
Recognizing hypoglycemia matters. Symptoms include shakiness, cold sweats, confusion, dizziness, rapid heartbeat, blurred vision, and unusual hunger. Severe episodes can cause slurred speech or seizures. Most people learn to feel the early warning signs and treat them quickly with fast-acting carbohydrates like glucose tablets or juice.
Injection site reactions are less common but worth knowing about. In trials, 2.7% of people using Lantus reported pain at the injection site, compared to 0.7% of those using an older type of long-acting insulin (NPH). Redness, itching, and mild swelling can also occur. These reactions are usually minor and temporary.
Biosimilar Alternatives
Biosimilars are near-identical versions of biologic drugs, similar to how generics work for standard medications. Several insulin glargine biosimilars have entered the U.S. market at lower cost than brand-name Lantus. If cost is a concern, ask your prescriber or pharmacist whether a biosimilar is available and appropriate for you, as some are designated “interchangeable,” meaning your pharmacist can substitute them without needing a new prescription from your doctor.
Tips for Daily Use
Pick a consistent time each day for your injection. Because Lantus works for up to 24 hours, taking it at roughly the same time keeps your background insulin level steady. Most people choose bedtime or morning, though either works.
Never share your SoloStar pen with another person, even if you change the needle. Pens can carry trace amounts of blood after injection, creating a risk of transmitting bloodborne infections. Each pen is a single-patient device.
Inspect the insulin before each use. Lantus should be clear and colorless. If it looks cloudy, has particles floating in it, or has changed color, don’t use it. Unlike some other insulins that are intentionally cloudy and need to be mixed, Lantus should never be shaken or diluted, and it should never be mixed with any other insulin in the same pen or syringe.